Non-Hodgkin's lymphoma of the thyroid

Primary Non-Hodgkin's Lymphomas of the Nasal and Mouth Cavity and the Waldeyer's Ring: A morphological and immunohistochemical study.

Leukemia & lymphoma·2016

Interdigitating Reticulum Cell Sarcoma Positive immunohistochemistry for HLA-DR and two other activation antigens, CD30(Ki-1) and CD25(IL2R).

Leukemia & lymphoma·2016

EGFR expression and activation are common in HER2 positive and triple-negative breast tumours.

Histology and histopathology·2010

Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.

Histopathology·2006

Comparative study of CD34, alpha-SMA and h-caldesmon expression in the stroma of gynaecomastia and male breast carcinoma.

Histopathology·2005

Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.

Acta neuropathologica·2004

Akkermansia muciniphila supports anti-PD-1 therapy in colorectal cancer: Butyrate-associated metabolic changes and CD8⁺ T-cell responses.

Pathology, research and practice·2026

A lactic acid-Chac1 axis regulates ferroptosis-associated cell death and tumor progression.

Pathology, research and practice·2026

Microparticles and colorectal cancer.

Pathology, research and practice·2026

ACOD1 enhances the ferroptosis resistance of tumor-associated macrophages through the KEAP1/NRF2 axis and promotes triple-negative breast cancer progression.

Pathology, research and practice·2026

The development of self-assembly in promoting diabetic wound healing.

Pathology, research and practice·2026

MARCH1 promotes malignant progression in lung adenocarcinoma by regulating PLPP3 ubiquitination.

Pathology, research and practice·2026

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

JTO clinical and research reports·2026

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Urologic oncology·2026

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics·2026

B-cells in breast cancer: current insights and challenges.

Frontiers in oncology·2026

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

Frontiers in oncology·2026

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Frontiers in oncology·2026

Related Experiment Videos

Non-Hodgkin's lymphoma of the thyroid

Related Concept Videos

Primary Non-Hodgkin's Lymphomas of the Nasal and Mouth Cavity and the Waldeyer's Ring: A morphological and immunohistochemical study.

Interdigitating Reticulum Cell Sarcoma Positive immunohistochemistry for HLA-DR and two other activation antigens, CD30(Ki-1) and CD25(IL2R).

EGFR expression and activation are common in HER2 positive and triple-negative breast tumours.

Update on extranodal lymphomas. Conclusions of the Workshop held by the EAHP and the SH in Thessaloniki, Greece.

Comparative study of CD34, alpha-SMA and h-caldesmon expression in the stroma of gynaecomastia and male breast carcinoma.

Relative expression of human telomerase catalytic subunit (hTERT) transcripts in astrocytic gliomas.

Akkermansia muciniphila supports anti-PD-1 therapy in colorectal cancer: Butyrate-associated metabolic changes and CD8⁺ T-cell responses.

A lactic acid-Chac1 axis regulates ferroptosis-associated cell death and tumor progression.

Microparticles and colorectal cancer.

ACOD1 enhances the ferroptosis resistance of tumor-associated macrophages through the KEAP1/NRF2 axis and promotes triple-negative breast cancer progression.

The development of self-assembly in promoting diabetic wound healing.

MARCH1 promotes malignant progression in lung adenocarcinoma by regulating PLPP3 ubiquitination.

Anakinra Prophylaxis for Recurrent Severe ICANS Associated With Tarlatamab in Small Cell Lung Cancer: Case Report.

Prognostic value of CD103+ tumor-infiltrating lymphocytes in bladder cancer: A systematic review and meta-analysis.

Immunotherapy for Glioma: A compartmental framework for resistance and rational combination design.

B-cells in breast cancer: current insights and challenges.

Tumor immunosenescence drives breast cancer progression and therapeutic resistance: mechanisms and emerging interventions.

The heterogeneous and dynamic immune-tumor interface in breast cancer.

Related Experiment Videos

Non-Hodgkin's lymphoma of the thyroid

Related Concept Videos

Related Articles